药物抑制的短暂的受体潜在离子通道安基林1对抗作用2-二马洛诺尼特利催剂诱导的皮肤损伤
Satyanarayana Achanta1, Narendranath Reddy Chintagari2, Shrilatha Balakrishna2
1Center for Translational Pain Medicine, Department of Anesthesiology (S.A., B.L., S.-E.J.) and Department of Pharmacology and Cancer Biology (S.-E.J.), Duke University School of Medicine, Durham, North Carolina; Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut (N.R.C., S.B.); and Integrated Toxicology and Environmental Health Program (ITEHP), Nicholas School of the Environment, Duke University, Durham, North Carolina (S.-E.J.) satya.achanta@duke.edu sven.jordt@duke.edu.
与普遍认为的相反,二二 (Chlorobenzalmalononitrile (CS)) 催气会导致持续的皮肤损伤. 针对TRPA1离子通道的治疗有效地减少了CS引起的皮肤损伤和疼痛.
科学领域:
- 毒理学 毒理学 毒理学
- 神经科学是一个神经科学.
- 皮肤病学 皮肤病学
背景情况:
- 二 (Chlorobenzalmalononitrile,CS) 是一种广泛使用的防暴剂.
- 人们普遍认为,CS暴露只会引起暂时和良性影响.
- 然而,CS可以引起严重的疼痛,炎症和皮肤损伤.
研究的目的:
- 研究TRPA1离子通道在CS引起的皮肤损伤中的作用.
- 评估TRPA1抑制剂作为对抗CS暴露的对策的疗效.
主要方法:
- 用CS剂应用于小鼠耳朵,以模拟皮肤损伤.
- 在暴露后使用TRPA1抑制剂 (HC-030031,A-967079).
- 测量了皮肤胀,血扩散和细胞因子水平.
- 对先进的TRPA1抗剂进行了体外测试.
主要成果:
- CS暴露引起了显著的组织胀,血扩散和炎症性细胞因子的增加.
- 脑脊髓引起的损伤是持久的,而不是短暂的.
- 用TRPA1抑制剂治疗显著降低了CS诱导的皮肤损伤参数.
- 先进的TRPA1抗体在体外显示出药理活性.
结论:
- TRPA1是CS诱导的疼痛和皮肤损伤的关键调解者.
- TRPA1抑制剂是对CS暴露的有效对策.
- 需要对TRPA1抗剂和消毒进行进一步的研究.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists


